Abstract. In this work the binding of V IV O 2+ and V IV O-complexes to serum albumins {human serum albumin (HSA), bovine serum albumin (BSA) and porcine serum albumin (PSA)} are studied using circular dichroism (CD), electron paramagnetic resonance (EPR) and visible absorption spectroscopy. The results confirm previous findings that V IV O 2+ occupies at least two types of binding sites on albumin: 'the strong vanadium binding site' (designated by VBS1) and 'the weak vanadium binding sites' (designated by VBS2). VBS1 binds 1 mol equivalent of V IV O 2+ . On the other hand VBS2 correspond to binding of several mol equivalents of V IV O, and studies done with PSA in the presence of excess Zn II ions indicate that VSB2 corresponds to two distinct types of sites. The hyperfine coupling constant A z for V IV O 2+ binding at VBS2 on HSA and BSA are all very similar (~168 × 10 -4 cm -1 ) but differ slightly on PSA (~166 × 10 -4 cm -1 ) due to differences in the binding sets. When (V IV O)-HSA systems are titrated with maltol ternary species of (maltol) m (V IV O) m HSA and (maltol) 2m (V IV O) m HSA stoichiometry form which are clearly distinguishable from the binary (V IV O)-HSA system by the type and intensity of the CD spectra recorded. Changes are also observable in the intensity of the X-band EPR spectra, but not much in the hyperfine coupling constants A z , which are all in the range 166-167 × 10 -4 cm -1 . The results further demonstrate that the presence of maltol may enhance the binding of V IV O to albumin. Key words: Oxovanadium(IV), Circular Dichroism, Electron Paramagnetic Resonance, maltol, human serum albumin, bovine serum albumin, porcine serum albumin.
Introduction
The interactions of V IV O 2+ with serum proteins are important to its pharmacokinetic properties. The studies carried out to investigate the significance of vanadium as well its compounds in biological systems have led to the discovery of its potential as a therapeutic agent. Many publications illustrate its insulin-mimetic [1, 2] , anti-cancer [3] [4] [5] , anti-parasitic [6, 7] antimicrobial [8, 9] and antispermicidal [10] actions. V IV O and its complexes show high potential for the treatment of type-2 diabetes, and prospective uses for other diseases [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] .
It is believed that ligands such as maltol, dhp (Hdhp = 1,2-dimethyl-3-hydroxy-4(1H)-pyridinone, Scheme 1), picolinato, dipicolinato and acetylacetonato, may enhance the insulin mimetic properties of V IV O 2+ [1, [12] [13] [14] [15] [16] [17] [18] [19] [20] . However, when V IV O 2+ is administered as a complex, designated here as V IV O(carrier) n , it may undergo transformations in the gastrointestinal tract, through the circulation and finally in the tissues and cells [1, [19] [20] [21] [22] [23] [24] [25] [26] . It was reported that the complex undergoes rapid dissociation at the site of absorption, both V IV O 2+ and the carrier ligand following different pharmacokinetic pathways [1, [18] [19] [20] . Notwithstanding, many other studies have shown differences in activity between V IV O 2+ administered as a salt (V IV OSO 4 ) and as V IV O(carrier) n complexes (examples in Figure 1 ) [17, 18, 24, 26] .
Albumin is the most abundant large globular protein in the blood serum of mammals and is important for several physiological functions [27, 28] . Albumin has multiple specific and non-specific binding sites where a large number of endogenous and exogenous substances bind. The composition of HSA, BSA and PSA are similar; however, there are some variations in the number and sequence of their amino acids [27] . Namely, HSA contains only one [29] tryptophan while both BSA and PSA contain two [27] each; due to this difference the molar absorptivity of the band at ~280 nm for HSA is about 20% lower than that of BSA.
Concerning metal ion binding, despite the lack of detailed structural information about the binding sites on human albumin, four sites have been described [30] : (1) the Amine Terminal Cu(II) and Ni(II) site, often designated by ATCUN is at the N-terminus, the primary binding site for Cu II and Ni II ; [27, 30] ; (2) the multi-metal binding site (MBS) which primarily binds Zn II and a few other +2 metal ions [30] ; (3) site B which is the primary binding site for Cd II but can also bind Zn II [30] [31] [32] , and (4) the reduced thiol of Cys-34, which binds gold and platinum compounds [30, 33] .
There are 14 conserved His residues in human, bovine and porcine albumins [31] , but only three of them are located close enough to each other in space to provide a strong binding site for metal ions. An important difference between the three albumins is the ATCUN motif: (i) HSA has Asp-1, Ala-2, and His-3 at the N-terminus, (ii) BSA has Asp-1, Thr-2 and His-3, while (iii) PSA has His-3 substituted by Tyr-3. [27, 34] Other groups such as carboxylates and amides may also play roles in metal ion binding to albumin. It is considered that for BSA the primary binding site for Cu II is also the 3 residues of its N-terminal site, while for PSA, although Cu-binding would be possible, data indicate it is elsewhere in the protein [30] . The positions of the CD bands and EPR parameters for Cu II bound at the MBS suggest coordination and tetragonal binding geometry, and globally the the similarity of the several spectroscopic parameters between albumins suggest that the MBS has been mostly conserved during evolution.
Several studies have reported the binding of V IV O 2+ to albumin [25, [34] [35] [36] [37] [38] [39] . Chasteen and Francavilla identified two classes of binding sites on albumin: 'strong' and 'weak' [39] . The ATCUN motif was reported to be the VSB1 site and to bind 1 mol equivalent of V IV O 2+ [27, 39] . The weak sites of V IV O 2+ (VBS2) were considered to consist of a number of non-specific interactions that may involve carboxylate or imidazole side chains of amino acid residues [38, 39] , and Chasteen reported at least five non-specific interactions [39] .
Garribba et al. detected a dinuclear (V IV O) 2 HSA species by EPR at -150 °C [36] . The spin state of this species is 1, it is observed up to a V IV O:HSA ratio of 1:1 and the intensity of the spectrum is very low. At V IV O:HSA > 1 another type of EPR spectrum (spin 1/2) becomes predominant and no other distinct type of spectrum is observed up to a V IV O:HSA ratio of 8:1. Notwithstanding, the V IV O binding to amino acid side chains of the ATCUN motif, if occurring, differs from Cu II binding to the same site. In studies with small oligopeptides, in the absence of a primary anchor donor group V IV O ions (similarly to Cu II ) are not able to induce the deprotonation of the amide groups [36, [40] [41] [42] ; in fact the N-terminal amino group is a suitable anchor for Cu II , but not for V IV O [40] [41] [42] [43] [44] [45] .
Sakurai & co-workers [34] compared the CD spectra of solutions containing BSA and V IV O 2+ and of solutions containing iodoacetamide-BSA and V IV O 2+ . The non-detection of the positive CD band at 590 nm was considered to demonstrate the binding of V IV O to the thiolate of Cys34; the second binding site of Cu II was also considered to be this thiolate donor [34] . However, this binding for Cu II contradicts the results of Bal [31] and those of other groups [37, 38] . So, up to date, the actual groups that form the vanadium binding sites are not well known.
CD and EPR data showed that V IV O 2+ occupies two types of binding sites in albumin, which compete not only with each other, but also with hydrolysis of the metal ion [37] . In one of the sites the resulting V IV O-HSA complex has a weak CD signal in the visible range and its X-band EPR spectrum may be easily measured. This was assigned to amino acid side chains of the ATCUN site. The other binding site showed stronger signals in the CD in the visible range and was assigned to the multi metal binding site (MBS) of HSA. However, the possibility of binding of at least 6 mol equivalents of V IV O to HSA suggests that the situation is more complex. Therefore, one of the objectives of this work is to clarify the nature of the V IV O 2+ binding sites at HSA. For this purpose we also include here studies of the V IV O + BSA and V IV O + PSA systems.
Vanadium(IV) and its complexes of maltol have attracted much attention due to their anti-diabetic effects [1] . V IV O 2+ is able to interact with maltol to form ternary species when bound to albumin, supporting the possibility of transport of V IV O 2+ in blood plasma in the form of V IV O-HSA-maltol species. The ternary species formed may be of two types: (V IV OL 2 ) n (HSA) or (V IV OL) n (HSA). The system has been studied by several groups [12] [13] [14] [15] 37] some indicating the formation of (V IV OL) n (HSA), others the formation of (V IV OL 2 ) n (HSA). In this work we also further study this system to clarify the type of V IV O-maltol-HSA species formed. 
Experimental

Materials and preparation of solutions
The chemical reagents and albumins were used as received from the supplier without further purification.
Millipore  water was used for the preparation of the solutions and a HEPES buffer was used in most experiments (except RT EPR). The composition of the buffer designated as HEPES-S used was: 50 mM HEPES (Sigma-Aldrich), 25 mM carbonate added as NaHCO 3 (Sigma-Aldrich), 1 mM phosphate added as NaH 2 PO 4 ·H 2 O (Merck), and 0.20 mM KCl (Merck); the buffer was adjusted to pH 7.4 using conc. KOH and conc. HCl.
Fatted HSA (A1653, fHSA) and defatted HSA (A3782, dHSA), defatted BSA (A-7511, dBSA), fatted BSA (A3675, fBSA) and fatted PSA (A1830, fPSA) were purchased from Sigma-Aldrich. Maltol, and V IV OSO 4 were also purchased form Sigma-Aldrich.
The molecular weight as well as the molar extinction coefficients used for the determination of albumin concentrations were: (1) 66.5 kDa; ε(278 nm) = 36850 M -1 cm -1 for fatted HSA and defatted HSA [46] [47] [48] [49] (2) [22, 36, 48] . These values were obtained from the indicated references and product information documents from Sigma.
Albumin solutions: The albumin solutions were prepared by dissolving the protein in HEPES-S buffer. The solutions were allowed to stand for at least 60 minutes to allow equilibration. During this period the solutions were gently swirled; strong agitation was never done. The concentrations were then determined by UV spectrophotometry. Argon was gently bubbled through all solutions prior to use to displace any oxygen that may be present, and these were kept and manipulated under the argon atmosphere inside a glove bag.
Metal ion solutions: with the exception of the V IV O stock solution {V IV O(ClO 4 ) 2 }, prepared as described previously [50] . Degassed and stored under nitrogen atmosphere in closed glassware, all other metal ion solutions were freshly prepared by dissolving them in Millipore  water. The concentration of the stock V IV O(ClO 4 ) 2 solution was 9.90 mM.
Titrations: in all titrations the albumin solution was titrated by adding μL aliquots of the other compounds to obtain the desired molar ratios. The UV-Vis and CD spectra of the solutions were measured, and samples were taken and frozen at 77 K for EPR measurements.
Spectroscopic measurements
The visible absorption spectra of the solutions were recorded on a Perkin Elmer Lambda 35 UV/Vis spectrophotometer in the range 400 - 1000 nm with quartz Suprasil ® cuvettes. The circular dichroism (CD) spectra of the solutions were recorded on a JASCO J-720 spectropolarimeter (JASCO, Hiroshima, Japan) using a red-sensitive photomultiplier (EXEL-308) in the visible region of the electromagnetic spectrum (400-1000 nm). Most of the CD recordings were done at ~25 ºC with a 50 mm quartz cell. One to three accumulations were made for each measurement. The CD spectra were obtained in mdeg units which were converted to ∆ε values (in M -1 cm -1 units) based on the concentration of the albumin present. ∆ε values may be positive or negative [51] and when it is stated that the CD signals increase or decrease, this corresponds to the |∆ε| values.
The X-band EPR (~9.46 GHz) spectra were measured either at room temperature (RT) or at liquid nitrogen (LN) temperature (77 K). The spectra at 77 K were recorded on a Bruker ESP 300E spectrometer. To improve the signal to noise ratio 10 scans were accumulated for each sample. The spectra acquisition parameters were constant for each batch of experiments. All measurements were done using 3 mm quartz tubes (Wilmad 707-SQ-250 M). The EPR samples contained 5% DMSO.
To facilitate the description of the composition of each solution we will often describe a solution that contains e.g. HSA and Cu II in a 1:2 molar ratio by Cu 2 HSA, or a solution with BSA and V IV O in a 1:4 molar ratio by (V IV O) 4 BSA. In some occasions a similar designation will be used to specify a particular metal complex species. The designation V IV O 2+ is used when referring to the V IV O(H 2 O) 5 2+ or V IV O 2+ as cations; the designation V IV O is used when referring to this unit in a complex species, e.g. (V IV O) 4 BSA.
Results and discussions
Binding sites of V IV O 2+ on albumin
The visible CD spectra pattern of (V IV O) m -HSA complexes is shown in Figures 1 and 2 . The (V IV O) m -HSA complexes produce both negative and positive bands in the visible range of the CD spectrum. The positive bands are observed approximately between 520 and 730 nm with band 'maxima' (λ max ) at ~588 nm, while the negative band appears between 730 nm and 1000 nm with λ max at ~832 nm. Another negative band is observed at λ < 520 nm.
Below 1 mol equivalent of V IV O 2+ the CD signals are very low ( Figure 1 ). This applies to both defatted and fatted HSA-V IV O complexes, but the intensity is significantly higher for the defatted (V IV O) m -HSA solutions. The intensity of the CD spectra globally increases upon addition of V IV O 2+ up to V IV O: HSA molar ratios of 9 ( Figure 2 ).
The d-d electronic transitions of (V IV O) m -HSA species is manifested in the CD spectrum in the visible range when it is coordinated by donor atoms where chirality is effectively transferred from the chiral centres of the protein to the V IV O centre [51] [52] [53] [54] [55] [56] [57] . Binding to donor groups of amino acid residues of albumin may thus result in the manifestation of d-d transitions in the visible CD spectrum [22, 31, 37] . Considering the many possible binding sites of V IV O 2+ on albumin, each mol equivalent of V IV O 2+ may produce a visible CD spectrum that may show some variations depending on the amino acid residues coordinating it and the environment of the site. What is measured is the sum of the CD signals corresponding to all complexes formed [50] [51] [52] [53] [54] [55] [56] [57] .
The zinc primary binding site (the MBS site) is at the interface of domains I and II of HSA. In the presence of fatty acids this site is disrupted, and the bound Zn II at this site decreases drastically in the presence of long chain fatty acids. This disruption is caused by a domain-domain movement that can be described as a rotation of domain I with respect to domain II [29] [30] [31] [32] . As a general remark to the spectra of Figure 1 we may emphasize that the CD spectra measured with solutions containing dHSA and V IV O 2+ are more intense than those with solutions containing fHSA and V IV O 2+ . This is an indication that some of the vanadium binding sites also involve residues of the MBS site, the measured |∆ε| values in the visible range being significantly lower in the case of fHSA-V IV O 2+ solutions. [1, 26, 36, 39] obtained EPR spectra in agreement with V IV O 2+ exhibiting two types of binding modes of which one is considered non-specific. Our group recently discussed metal competition studies of Cu(II) and Zn(II) as metal probes for V IV O 2+ binding with HSA [37] . These studies confirmed the involvement of amino acid side chains of the ATCUN and MBS sites. In this work we also examine the metal competition studies of Cu(II) and Zn(II) as metal probes with V IV O 2+ binding with BSA and PSA.
Studies with defatted BSA and V IV O 2+
BSA, like HSA, was reported to have two binding sites for metals. One site is the MBS which is the principal binding site, while the second site is the site B or Cd 2+ primary site [30] . The CD spectra in the visible range observed after titrating 0.45 mM of BSA (defatted) with increasing mol equivalents (0.6 to 4) of V IV O showed positive and negative features similar to (V IV O) m HSA CD spectra (Fig. 3b) . Two main bands, positive (~588 nm) and negative (~832 nm), showed up which globally increase in intensity with increasing V IV O 2+ concentration (Fig.  3a) , but other CD bands are detected, e.g. at λ < 400 nm, at λ max ≈ 700 nm and at λ max > 950 nm. As for the HSA-V IV O system the CD band pattern is complex and changes upon addition of V IV OSO 4 . The type of spectra obtained at low V IV O:HSA molar ratios (up to 2:1) differ from those obtained at higher molar ratios, e.g. 4:1. Thus different sites are occupied as V IV O 2+ is progressively added to the defatted BSA.
Yasui et al. [34] also observed positive CD with λ max at ~590 nm when 0.5 mM BSA was titrated with 0-1.5 mM V IV O 2+ at pH of 7.4. However, the spectra they obtained do not coincide with those obtained here, and no measurements were made for λ > 800 nm.
As for the studies with fatted/defatted HSA and V IV O 2+ , the EPR spectra of the solutions of Figure 3 agree when simulated as consisting of two types of signals. The parameters of V IV O 2+ occupying VBS2 are: A z = 167.6 × 10 -4 cm -1 and g z = 1.940. The A z and g z values obtained for V IV O 2+ binding to the VBS2 on BSA are close to those obtained for fatted/defatted HSA and V IV O 2+ , and agree with those reported by Orvig [1] and Sanna [36] .
Incremental additions of Zn II ions to solutions containing 4 mol equiv of V IV O decrease the intensities of the bands at ~ 830 nm and ~588 nm ( Figure SI-1) . This means that Zn 2+ displaces the V IV O-species responsible for the ~588 and ~830 nm bands. As Zn 2+ binds to the MBS site of BSA, these V IV O-complexes were probably bound close to the MBS residues. The EPR spectra shown in Figure 4 indicate that some V IV O 2+ remained bound to dBSA when Zn II was added; in fact the V IV O EPR signals are still observable after addition of 3 mol equivalents of Zn II . Only one type of signal is observed in the three spectra, but the peaks decrease in intensity with the amount of Zn II added. At pH 7.4 the V IV O 2+ displaced by Zn 2+ either precipitates as V IV O(OH) 2 , or forms EPR-silent [(V IV O)(OH) 5 -] n , or oxidizes to V V , and the V IV O EPR signal detected after addition of Zn II is thus not due to V IV O bound to the MBS site. This binding yields weak CD signals for λ > 520 nm and the EPR signals are either due to V IV O 2+ bound to the ATCUN site (as suggested in [37] ) and/or to V IV O 2+ bound to other sites, e.g. accessible N-imidazole atoms of His residues or O-carboxylate atoms of Asp or Glu residues.
Studies with fatted PSA and V IV O 2+
Further studies to determine the binding site on HSA were carried out with fatted PSA. PSA lacks His-3 residue which is required for the formation of the ATCUN motif, the primary binding site of Cu II on HSA and BSA. As stated above and in the SI section, PSA differs from HSA and BSA in several aspects, namely the substitution of His-3 by Tyr-3. Thus the N-terminal strong Cu II and Ni II binding site (ATCUN) does not exist in PSA [27, 30, 34] . The MBS however is preserved in PSA [31] . PSA also has two more His residues than the 16 in both HSA and BSA. Additionally, PSA binds Zn II and Cd II at the MBS site much more strongly than HSA and BSA [34] .
The spectra shown in Figure 5 indicate that when V IV O 2+ was progressively added to ~630 µM fatted PSA the CD band pattern obtained in the visible range totally differs from those of HSA and BSA, as is also emphasized in Figure 6 . Two types of CD spectra may be considered. Upon addition of 1 - 2 mol equivalents of Zn II to a solution with a V IV O 2+ :PSA molar ratio of 6:1 ( Figure SI-2) , the intensity of the bands at ~ 524 nm and ~ 590 nm decreased. However, it appears that Zn II does not interfere much with the sites responsible for the bands at 700 and 880 nm.
The (V IV O) m PSA (m = 1,2,6) EPR spectra depicted in Figure 7 show that the resonant field positions of all samples are the same even after addition of Zn II . This suggests that only one type of binding set is present [with spin Hamiltonian parameters: A z = 165.9×10 -4 cm -1 and g z = 1.941}]. Note that if a 'strong site' similar to the one for HSA exists, it will not be readily observable in the X-band EPR spectrum at pH 7.4. The effect of Zn II on the binding of V IV O 2+ to PSA may be seen by the decrease in intensity and linewidths of the EPR spectrum of the solution containing 3 mol equivalents of Zn II (1:6:3). This together with the decrease in intensities observed in some bands of the visible CD experiments show that Zn II partly displaces V IV O 2+ from some of its sites, but in a way quite distinct from HSA or BSA. This also indirectly shows that the V IV O binding at HSA or BSA certainly also involves amino acid residues of the ATCUN site. Finally, the observation of rather strong EPR signals in solutions containing 1:6:3 (PSA: V IV O: Zn II ) molar ratios, indicates that a significant amount of V IV O 2+ ions are bound to sites other than the ATCUN (not present in PSA), or the MBS sites. These sites may be e.g. accessible N-imidazole atoms of His residues or O-carboxylate atoms of Asp or Glu residues, but the observation of rather strong CD signals due to this type of binding suggests that at least two protein donor atoms are bound to the V IV O centers at these sites. The presence of a 3 rd type of site was previously suggested for Cu II binding to PSA [31] .
Judging from the EPR parameters in Table 1 Further studies to determine the binding site on HSA were carried out with fatted PSA.
Bal et al. [31] reported that titration of 0.67 mM PSA solution with Cu II ions at pH 7.4 yielded only 'one' positive band between 500 and 800 nm: (i) at λ max ≈ 670 nm for ~1 mol equivalent of Cu II added, and (ii) at λ max ≈ 650 nm for ~2 mol equivalent of Cu II . Contrary to these findings we observed only one positive band between 500 and ~ 900 nm with λ max ≈ 650 nm when a 0.60 mM fPSA solution was titrated with either 1 and ~2 mol equivalents of Cu II solution ( Figure SI-3) . It is not clear why this was so. Positive bands also appeared below ca. 500 nm.
Yasui et al. [34] reported that upon titration of PSA with V IV O 2+ they observed a positive band at 590 nm, but no figure was presented; when the resulting solution was titrated with a Cu II solution a positive band at 690 nm developed. By implication, they attributed the band at 690 nm to Cu II binding to its site on PSA [34] . These authors did not specify whether fatted or defatted PSA was used (presumably it was fatted PSA).
Our CD spectra were obtained with a red-sensitive photomultiplier, thus allowing recording the CD signal up to 1000 nm. When 0.60 mM fPSA was titrated with 0.5 to 5 mol equivalents of V IV O 2+ , four bands were observed in the 500-1000 nm region, Figure 8 . The bands have λ max at ~525 nm (Δε < 0), ~590 nm (Δε > 0), ~700 nm (Δε < 0) and ~860 nm (Δε > 0). The appearance of the band at ~590 nm is in agreement with the ~590 nm band observed by Yasui et al. [34] . Considering the CD spectra depicted in Figure 8 , it is predicted that the positive CD band at 500-800 nm for the Cu-PSA species may overlap with the (-, +, -) band pattern observed for the V IV O-PSA species. Hence, if to a solution containing PSA and Cu II a solution containing V IV O 2+ is added, changes will be observed in the CD spectra that will depend on the relative amount of Cu II The decrease in intensity of the CD band due to the Cu-PSA species as V IV O 2+ is added indicates the displacement of Cu II from the MBS site of PSA. Also there is a shift in the λ max from 650 nm to ~690 nm as new species form, this being in agreement with the observation of Yasui et al. [34] who observed the appearance of the ~690 nm band after addition of Cu II solution to solutions containing PSA and V IV O 2+ . However, it is clear that the CD signals recorded have contributions from several V IV O-PSA and Cu II -PSA species, as may be inferred from Figure 9 . Figure 10a was obtained by subtracting the CD spectra of solutions containing PSA and Cu II {at 2:1 Cu(II):PSA molar ratio} from those of the solutions containing PSA, Cu II and incremental additions of V IV O 2+ (Figure 9 ). This gives a 'measure' of the displacement of the Cu 2+ ions from fPSA by the V IV O 2+ added. When the experimental CD spectra shown in Figure 10 were subtracted from the corresponding sum of Cu 2 PSA and (V IV O) m -PSA (m = 1, 2, 3, 4, 5, 6), the spectra shown in Figure  10b were obtained. The patterns shown in Figure 10b resemble the spectra shown in Figure 5 . This gives further proof that, besides substituting Cu II at the MBS binding site, V IV O 2+ appears to bind sites not previously occupied by Cu II .
In Figure SI -4 apparently only the Cu II spectrum with one resonant field position is observed in the X-band EPR spectrum of the frozen solutions containing Cu 2 HSA + V IV O 2+ in the molar ratios indicated. The corresponding EPR parameters are: A z = 174.0 × 10 -4 cm -1 and g z = 2.27. These values differ from those reported by Bal et al. [31] for Cu II binding to PSA: (1) A z = 188 × 10 -4 cm -1 and g z = 2.26 for a site designated as I, and (2) A z = 184 × 10 -4 cm -1 and g z = 2.29 to site II (the MBS site). The EPR signals of V IV O-species are not clearly seen, although from the CD spectra it is clear that it partly displaced Cu 2+ from PSA. A rather similar situation was also found in the case of the Cu II -V IV O-HSA system [37] . This suggests that a significant part of the V IV O species bind HSA and PSA at these sites forming EPR-silent species (but active in CD).
(V IV O) m HSA interaction with maltol
To gain more insight into the possible interaction of V IV O 2+ with maltol in blood plasma in circulation, studies were carried out by titrating V IV O 2+ -HSA complexes with BMOV and maltol, and monitoring the interaction by CD and EPR. Some of these results were reported recently [37] .
When 0.67 mM (V IV O) 0.9 HSA (fatted) was titrated with 0.2-2.6 mole equivalents of maltol, the CD spectra depicted in Figure 11a were obtained. Very clear changes are seen in the CD spectra in the visible region upon addition of maltol, particularly in the 650-1000 nm range, but changes are also observed in the bands at λ < 650 nm. Other experiments but starting with different V IV O:HSA ratios are also shown in Figure 12 . Globally the type of spectra recorded differ from those of solutions containing V IV O and HSA, clearly demonstrating that the coordination environment of V IV O 2+ bound to HSA is modified when maltol is added to the system. According to Orvig [1] , when V IV O 2+ is added to albumin as ions, the first mol equivalent binds VBS1 and further added moles of V IV O 2+ bind the VBS2-type sites. This is in line with Sanna's report of the formation of multinuclear species when the V IV O 2+ /albumin ratio is > 1 [36] . Depending on the amount of V IV O 2+ added to HSA, there may be several (V IV O) m HSA (m > 1) species available to interact with maltol, and at higher ratios of V IV O:HSA there will be a higher number of V IV Ocentres available to interact with maltol, thus producing more intense CD spectra in the visible region. The system containing e.g. 1:3.5:10.5 (HSA:V IV O:maltol) will therefore have more intense CD signals in the visible region than its equivalent containing 1:1.8:5.3 (HSA: V IV O 2+ : maltol). However, for each type of chiral V IV O-species formed, the increase in its concen- 1, 2, 3, 4, 5, 6 ). Measurements were carried out in HEPES-S buffer (pH = 7.4). [50] [51] [52] [53] [54] [55] [56] [57] .
Observation of the patterns of the CD bands in Figures 11  and 12 , namely the relative intensity of the bands at 530-590 nm and 750-800 nm, show the formation of at least two types of chiral species: (1) when the ratio of maltol:V IV O 2+ < 1, and (2) when it is >1. In Figure 11b an isodichroic point is observed at λ ≈ 507 nm, Δε ≈ -0.025 M -1 cm -1 suggesting the existence of two distinct types of chiral species in equilibrium when the maltol:V IV O 2+ ratio is <1. When the maltol/V IV O 2+ ratio was increased further, e.g. Figure 11c and 11d, the type of CD spectra recorded continue to change suggesting the formation of a 3 rd distinct type of chiral species. Figure 12 also illustrates the formation of these three distinct types of chiral V IV O-species.
Thus important information may be obtained from As demonstrated previously [37, 38] and emphasized here, the CD and EPR spectra are compatible with the formation of at least two sets of species (possibly three) when HSA is titrated with V IV O 2+ . Moreover, the oligomeric forms of V IV O formed at VBS1, and possibly also at other sites are not easily observable in the X-band EPR spectrum at pH 7.4, hence its weak intensity, Figure 13 . Upon addition of maltol, this binds to the V IV O centers, the intensity of the EPR signals increase significantly up to 1:2 (V IV O:maltol) molar ratio, but not much more after further additions of maltol. Moreover, the field positions do not change suggesting that the V IV O-maltol-HSA species formed correspond to identical binding sets, which is certainly not the case, because the type of CD spectra recorded changes.
As shown by the CD spectra, distinct species form when 0, 2.8, 8.3, 13.8 and 16.5 mol equivalents of maltol were added to e.g. 0.65 mM (V IV O) 3.4 HSA. However, Fig. 13 shows the presence of apparently only 'one species' for each spectrum. In fact, the corresponding EPR parameters of the species formed upon each addition of maltol (Table 2) Table 2 we may state that in the solutions studied the amount of BMOV formed, in any, is small. Thus, the possible stoichiometry of the species that may form are ( 
Conclusions
Reviewing the study of the interaction of V IV O with HSA, including the use of EPR and CD spectra, as well as metal competition studies with Cu II and Zn II as metal probes, the results confirmed that at least two types of binding sites are present in HSA, more probably three distinct types of sites, which compete not only with each other, but also with hydrolysis of the metal ion. The systems are quite complex and the studies are particularly difficult with fatted albumins where conformational changes, induced by the binding of fatty acids, decrease the ability of V IV O to bind albumin, lowering the intensity of the CD and EPR spectra measured [37] .
In one of the sites the resulting V IV O-HSA complex has a weak visible CD signal and its X-band EPR spectrum may be measured. This was assigned to amino acid side chains of the ATCUN site, but with a distinct binding set from that of Cu 2+ [37] . The other binding site shows stronger signals in the CD in the visible range and was assigned to the multi metal binding site (MBS) of HSA. The CD and EPR data recorded with the PSA + V IV O 2+ system (PSA does not contain the ATCUN site) in the presence of an excess of Zn II indicates that a 3 rd type of site is present in PSA but probably also in HSA and BSA.
The EPR and CD studies carried out with the HSA-V IV Omaltol system indicate that at least two types of chiral V IV Omaltol complexes form with 1:1 and 1:2 V IV O:maltol stoichiometry, the (maltol) 2m (V IV O) m HSA type species predominating if enough maltol is present in the solutions.
Not considering the probable binding to transferrin, if both V IV O 2+ and maltol are present in circulating blood and if equilibrium conditions are achieved, V IV O 2+ cations may be transported as HSA-V IV O-maltol species. SI-4 (old 14) . The X-band EPR frozen solution spectra (at 77 K) of Cu 2 PSA recorded in the presence of 2 (1:2:2) and 5 (1:2:5) mol equivalents of V IV O(ClO 4 ) 2 . The A z values were obtained by simulation of spectra [58] . The solutions were prepared in HEPES-S buffer (pH 7.4). SI-1 (old Fig. 4) . CD spectra of titration of solutions containing 0.5 mM dBSA, V IV OSO 4 and ZnCl 2 solution. The defatted BSA was first loaded with ~4 mol equivalents of V IV O 2+ . The mol equivalents of added ZnCl 2 are: 1, 2, and 3. Measurements were carried out in HEPES-S buffer (pH=7.4), with an optical path of 5 cm. 
